Riximyo

Indicated For

Non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis

About This Medication

# Sandoz PLUS Patient Guide: How to Get Riximyo (rituximab) at Low or No Cost Riximyo (rituximab-pvvr) is a biosimilar to Rituxan, used to treat conditions like non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and others by targeting CD20-positive B-cells to reduce abnormal cell growth.[1][2] The **Sandoz PLUS** program, offered by Sandoz, helps eligible patients access Riximyo at low or no cost through patient assistance, co-pay support, and other services, primarily for uninsured, underinsured, or commercially insured individuals meeting specific criteria.[1][2][3] ## Who Qualifies for Sandoz PLUS? The program targets patients facing financial barriers to Riximyo. Key eligibility groups include: - **Uninsured or functionally uninsured** patients with household income below program limits (typically up to 400-500% of the Federal Poverty Level, or FPL, though exact thresholds vary; contact program for details).[1][3] - **Commercially insured** patients eligible for co-pay assistance (as low as $0, up to annual limits like $10,000 for similar programs).[2][3] - U.S. residents (including Puerto Rico) with a valid prescription for an FDA-approved indication.[1] **Exclusions**: Generally not available for Medicare, Medicaid, VA, TRICARE, or other government programs.[2][3] ## About Riximyo **Riximyo** is a biosimilar monoclonal antibody to rituximab, approved for the same indications as Rituxan, including: - Relapsed or refractory low-grade or follicular CD20-positive B-cell non-Hodgkin lymphoma (NHL). - Previously untreated follicular NHL. - Microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA). - Rheumatoid arthritis (with methotrexate). - Chronic lymphocytic leukemia (CLL). Administered intravenously in a healthcare setting, it works by binding to CD20 on B-cells, leading to cell destruction. As a biosimilar, Riximyo offers similar efficacy and safety at potentially lower cost.[3] Always consult your doctor for personalized advice. ## Income Eligibility Breakdown Sandoz PLUS bases eligibility on household income relative to FPL. While specific Riximyo thresholds are not publicly detailed, Sandoz programs like One Source follow patterns up to 400-500% FPL for patient assistance.[1][3] Use this table as a general guide (2026 FPL estimates; verify current levels): | Household Size | 100% FPL | 400% FPL | 500% FPL | |----------------|----------|----------|----------| | 1 Person | $15,060 | $60,240 | $75,300 | | 2 People | $20,440 | $81,760 | $102,200| | 3 People | $25,820 | $103,280| $129,100| | 4 People | $31,200 | $124,800| $156,000| *Add ~$5,380 per additional person for FPL calculations. Income includes most sources; deductions may apply. Call program to confirm.[1][3]* ## Insurance Requirements - **No insurance needed** for free medication via patient assistance (uninsured/underinsured).[1] - **Commercial insurance required** for co-pay cards (not valid for government insurance).[2][3] - Medicare/Medicaid patients typically ineligible for co-pay help but may qualify for assistance foundations.[3] - Submit EOB or claim forms for reimbursement support.[2] ## Step-by-Step Application Process 1. **Get a prescription**: Ask your doctor for Riximyo and discuss Sandoz PLUS. 2. **Check eligibility**: Call 1-844-726-3691 (Mon-Fri, 8am-8pm ET) or visit Sandoz OneSource site to screen.[1][3] 3. **Enroll**: - **Online**: HCP or patient completes form (similar to OneSource enrollment).[2][4] - **Phone**: Call support line for case manager assistance.[2] - **Fax**: Submit enrollment form to provided number.[2] 4. **Provide documents**: Proof of income (tax returns, pay stubs), prescription, insurance details (if applicable).[1] 5. **Approval**: Receive confirmation; cards issued immediately for co-pay qualifiers.[2] HCPs can enroll patients directly.[1][2] ## Timeline and Delivery - **Processing**: 1-2 weeks for assistance; co-pay cards instant upon approval.[1][2] - **Delivery**: Free medication shipped to doctor's office or home; specialty pharmacy coordination.[1][3] - **Refills**: Automatic reminders via text/phone; reauthorization may apply annually.[2] ## Alternatives if Denied - **Appeal**: Submit additional docs or contact case manager.[2] - **Biosimilar alternatives**: - Rituxan (rituximab) - Truxima (rituximab-abbs) - Riabni (rituximab-arrx) - Ruxience (rituximab-pvvr) Their programs (e.g., Genentech for Rituxan) may have different criteria.[3] - **Other options**: Novartis Patient Assistance Foundation (800-277-2254), state programs, or 340B clinics.[3] ## Additional Support - Nurse ambassadors for training. - Reimbursement help (benefits investigation, prior auth via CoverMyMeds).[2] - Product replacement for spoiled meds.[3] ## Disclaimer This guide is for informational purposes based on available Sandoz program details as of 2026. Eligibility, terms, and availability can change; contact Sandoz PLUS directly (1-844-726-3691) or your healthcare provider for latest info. Not a substitute for medical or financial advice. Program not valid where prohibited; patient responsible for compliance with insurance rules.[1][2][3]

Program information last verified: March 25, 2026